Hartmut Link

14.1k citations
190 papers · 10.9k · 3 hit papers · h-index 47

Impact in

  • Hematology top 0.2%
    • Acute Myeloid Leukemia Research
    • Hematopoietic Stem Cell Transplantation
    • Erythropoietin and Anemia Treatment
    • Chronic Myeloid Leukemia Treatments
  • Oncology top 0.5%
    • Colorectal Cancer Treatments and Studies
    • Neutropenia and Cancer Infections
    • Colorectal Cancer Surgical Treatments

Papers in

    • Acute Myeloid Leukemia Research 32
    • Hematopoietic Stem Cell Transplantation 29
    • Chronic Myeloid Leukemia Treatments 14
    • Erythropoietin and Anemia Treatment 13
    • Neutropenia and Cancer Infections 40
    • Colorectal Cancer Treatments and Studies 7

Hartmut Link

162 papers receiving 10.4k citations

Hartmut Link's Hit Papers

Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial 2015 · 350 citations
3500+4+8Years since publication4008001.2k

Peers

Hartmut Link
Comparison fields: 5 of 121
  • Hematology 3.5k
  • Oncology 3.2k
  • Biochemistry 271
  • Molecular Biology 1.7k
  • Cancer Research 349
Replace Saroj Vadhan‐Raj with:
Saroj Vadhan‐Raj United States
Cihan Ay Austria
Giuseppe Avvisati Italy
Anna Falanga Italy
Xavier Thomas France
Pau Montesinos Spain
Sherry A. Pierce United States
David H. Henry United States
Shinji NAKAO Japan
Guillermo Francisco Sanz Spain
Hartmut Link relative to Saroj Vadhan‐Raj United States Saroj Vadhan‐Raj's profile →
Citations per field
00.5×2×2.7×
Saroj Vadhan‐Raj · 1×
Citations per year

Countries citing papers authored by Hartmut Link

Since Specialization
Citations

This map shows the geographic impact of Hartmut Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Link more than expected).

Fields of papers citing papers by Hartmut Link

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hartmut Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Link. The network helps show where Hartmut Link may publish in the future.

Co-authors

The 25 scholars most cited alongside Hartmut Link, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hartmut Link Line = papers co-authored together Hartmut Link links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 190 papers — load more, or switch the sort, to bring in the rest.

#Work
1
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
Hit paper breakdown →
20141434
2
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Hit paper breakdown →
20131275
3 1996501
4 1993433
5 2012384
6
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
Hit paper breakdown →
2015350
7 2016310
8 2006305
9 2017263
10 2004253
11 1998228
12 2017205
13 2013201
14 2011189
15 2003185
16 1992157
17 2003155
18 2007138
19 2013136
20 2008135

About Hartmut Link

Hartmut Link is a scholar working on Hematology, Oncology, Pathology and Forensic Medicine, Public Health, Environmental and Occupational Health and Pulmonary and Respiratory Medicine, having authored 190 papers that have together received 10.9k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (40 papers), Acute Myeloid Leukemia Research (32 papers), Hematopoietic Stem Cell Transplantation (29 papers), Chronic Myeloid Leukemia Treatments (14 papers), Erythropoietin and Anemia Treatment (13 papers), Retinoids in leukemia and cellular processes (10 papers), Colorectal Cancer Treatments and Studies (7 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Hematology (3.5k citations), Oncology (3.2k citations), Biochemistry (271 citations), Molecular Biology (1.7k citations) and Cancer Research (349 citations). Hartmut Link has collaborated with scholars based in Germany, Switzerland and France. Frequent co-authors include Matti Aapro, Carsten Bokemeyer, Anders Österborg, Jan Foubert, Pierre Soubeyran, Lazzaro Repetto, Adel Courdi, Georg Maschmeyer, Augustin Ferrant and Norbert Schmitz. Their work appears in journals such as Annals of Hematology, Blood, Supportive Care in Cancer, Annals of Oncology and British Journal of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact